A fully human connective tissue growth factor blocking monoclonal antibody ameliorates experimental rheumatoid arthritis through inhibiting angiogenesis

BACKGROUND: Connective tissue growth factor (CTGF) plays a pivotal role in the pathogenesis of rheumatoid arthritis (RA) by facilitating angiogenesis and is a promising therapeutic target for RA treatment. Herein, we generated a fully human CTGF blocking monoclonal antibody (mAb) through phage displ...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Yang, Wu, Gan, Jin, Jiayi, Wang, Hao, Zhang, Jiani, Liu, Li, Zhao, Heping, Wang, Jianguang, Yang, Xinyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985226/
https://www.ncbi.nlm.nih.gov/pubmed/36869335
http://dx.doi.org/10.1186/s12896-023-00776-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985226/
https://www.ncbi.nlm.nih.gov/pubmed/36869335
http://dx.doi.org/10.1186/s12896-023-00776-8

Ejemplares similares